Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02646631 · ClinicalTrials.gov registry record · NA
Behavioral and Educational Tools to Improve Epilepsy Care
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02646631: Completed NA study, sponsored by NYU Langone Health.
NCT02646631 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02646631, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The long-term goal of this research is to improve seizure control among patients with epilepsy, which has the potential to improve quality of life for thousands of people living with epilepsy and reduce health care utilization, social and economic costs, and epilepsy-related mortalities. Participants who are suffering from epilepsy will be randomized to receive usual care (UC), a smartphone-based self-management intervention called Management of Risks in Epilepsy (MORE), or MORE + telephone-based motivational interviewing (MI). Participants will be followed for 3 months.
Interventions
- OTHER Usual Care
- OTHER Educational Materials
- BEHAVIORAL Management of Risks in Epilepsy (MORE)
- BEHAVIORAL Telephone-based motivational interviewing (MORE+MI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-11-20 |
| Phase | NA |
What the finished NCT02646631 record still lists
NCT02646631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Usual Care is the first listed.
NCT02646631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02646631 about?
NCT02646631 is a clinical study titled "Behavioral and Educational Tools to Improve Epilepsy Care". The long-term goal of this research is to improve seizure control among patients with epilepsy, which has the potential to improve quality of life for thousands of people living with epilepsy and reduce health care utilization, social and economic costs, and epilepsy-related mortalities. Participant...
What is the current status of trial NCT02646631?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2016-09. Estimated completion is 2017-11-20.
What interventions are being tested in trial NCT02646631?
The interventions under investigation include: Usual Care (OTHER), Educational Materials (OTHER), Management of Risks in Epilepsy (MORE) (BEHAVIORAL), Telephone-based motivational interviewing (MORE+MI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02646631?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02646631's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia